GLPBio

Apoptosis

Read More about this category

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

 

References:

1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.

2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.

3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.

4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.

5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Research Areas

Products Related to Apoptosis(3359)

  • GC71833 structure
    GC718335-Aminolevulinic acid-d2 hydrochloride
    CAS: 187237-35-0
    Purity: >91.00%

    5-Aminolevulinic acid-d2 hydrochloride está marcado con deuterio 5-aminolevulínico clorclor.

  • GC71915 structure
    GC71915Tanshinone IIB
    CAS: 17397-93-2
    Purity: >99.00%

    Tanshinone IIB es un componente activo importante de las raíces de Salvia miltiorrhiza (Danshen) ampliamente utilizado para la investigación de derrames cerebrales y enfermedades coronarias en los países asiáticos.

  • GC71968 structure
    GC71968Celosin K
    CAS: 1950579-53-9
    Purity: >99.00%

    Celosin K (compuesto 8) puede ser aislado de las semillas de Semen Celosiae.

  • GC71997 structure
    GC71997Alphitolic acid
    CAS: 19533-92-7
    Purity: >98.00%

    Alphitolic acid es un triterpeno pentacíclico con esqueleto tipo lupano. Cuenta con propiedades antiinflamatorias y citotóxicas muy marcadas.

  • GC72001 structure
    GC72001Phellamurin
    CAS: 52589-11-4

    Phellamurin es un glucósido de flavonona de las hojas de Phellodendron amurense e inhila la p-glicoproteína intestinal.

  • GC72012 structure
    GC72012Dehydrocrenatidine
    CAS: 65236-62-6
    Purity: >98.00%

    Dehydrocrenatidine, un alcaloide natural, es un inhibidor específico de JAK.

  • GC72018 structure
    GC72018Goniothalamin
    CAS: 17303-67-2
    Purity: >98.00%

    Goniothalamin (GTN) es estirillactona con propiedades anticancerígenas, antiinflam, inmunosupres.

  • GC72054 structure
    GC72054Obovatol
    CAS: 83864-78-2
    Purity: >99.00%

    Obovatol es un lignan de éter bifenílico aislado de las hojas de Magnolia obovata Thunb.

  • GC72061 structure
    GC72061β-Phellandrene
    CAS: 555-10-2
    Purity: >99.50%

    β-Phellandrene se obtiene de Carum petroselinum.

  • GC72103 structure
    GC72103Kp7-6
    CAS: 629628-53-1
    Purity: >98.00%

    Kp7-6, un péptido mimético Fas, es un antagonista Fas/FasL.

  • GC72146 structure
    GC72146WP9QY TFA
    Purity: >99.00%

    WP9QY TFA, TNF-a antagonista, TNF-a antagonista es un péptido biológico activo.

  • GC72147 structure
    GC72147Mca-YVADAP-Lys(Dnp)-OH TFA
    Purity: >98.00%

    Mca-YVADAP-Lys(Dnp)-OH TFA es un sustrfluorpara la caspasa-1 y la enzima convertide angiotensina 2 ACE2.

  • GC72183 structure
    GC72183[D-Leu-4]-OB3
    CAS: 289056-32-2
    Purity: >99.00%

    [D-Leu-4]-OB3 inhila la expresión de genes proinflam, proliferativos y metastásicos y la expresión de pd-l1.

  • GC72186 structure
    GC72186WLSEAGPVVTVRALRGTGSW
    CAS: 771479-86-8
    Purity: >96.00%

    WLSEAGPVVTVRALRGTGSW es un péptido específico de cardiomioci.

  • GC72191 structure
    GC72191Pep19-2.5
    CAS: 1322711-38-5
    Purity: >98.00%

    Pep19-2.5 es un péptido sintético y antitoxina, bloquea la cascada de señalización de endotoxinas intrac.

  • GC72216 structure
    GC72216(Gly14)-Humanin (human) (acetate)
    Purity: >98.00%

    (Gly14)-Humanin (human) (acetate) es un análogo de la humanina en la que el 14 º aminoácido serina fue reemplazado con glicina (Gly).

  • GC72251 structure
    GC72251Tripeptide-32
    CAS: 1185583-20-3
    Purity: >99.00%

    Tripeptide-32 es un péptido bioactivo con efecto anti-envejecimiento y se ha utilizado como ingrediente cosmé.

  • GC72318 structure
    GC72318Tulisokibart
    CAS: 2648504-55-4
    Purity: 95.00%

    Tulisokibart (PRA023) es un anticuerpo monoclonal IgG1-κ dirigido a TNFSF15/TL1A.

  • GC72319 structure
    GC72319Atrosab
    CAS: 1365659-05-7
    Purity: >96.00%

    Atrosab es un anticuerpo anti-TNFR1 anti-igg1.

  • GC72337 structure
    GC72337Anti-Mouse 4-1BB/CD137 Antibody (3H3)
    Purity: >99.00%

    Anti-Mouse 4-1BB/CD137 Antibody (3H3) es un inhibide anticuerpos anti-ratón 4-1BB IgG2a derivado de la rata huésped.

  • GC72359 structure
    GC72359Quilizumab
    CAS: 1228538-47-3
    Purity: >96.00%

    Quilizumab (anticuerpo anti-humano NGcGM3 recombinante) es un anticuerpo monoclonal IgG1κ humani.

  • GC72360 structure
    GC72360Ruplizumab
    CAS: 220651-94-5
    Purity: >99.00%

    Ruplizumab (BG 9588) es un anticuerpo monoclonal anti-CD40L (Receptor TNF) IgG1κ.

  • GC72364 structure
    GC72364Toralizumab
    CAS: 252662-47-8
    Purity: 95.00%

    Toralizumab (IDEC-131) es un anticuerpo monoclonal humani(mAb) contra CD40L (CD154) compuesto por cadenas pesadas gamma 1 humanas y cadenas ligeras Kappa humanas.

  • GC72365 structure
    GC72365Visilizumab
    CAS: 219716-33-3
    Purity: >98.00%

    Visilizumab (anticuerpo anti-humano CD3E recombinante) es un anticuerpo monoclonal IgG2 humanide Unión al receptor anti-CD3.